Email list hosting service & mailing list manager


Re: Financial Times about Swets Shaare Zedek Medical Library 23 Sep 2004 12:49 UTC

I have no dealings with Swets but was a customer of divine, Rowecom, Faxon
etc. Worrying won't help but you'll probably do it anyway. I know I would.
However, speaking as one who was badly burned in December 2002, I would
strongly recommend not transferring any amount of money whatsoever to Swets
or anyone who deals with them until you can get definite assurance from
someone who is qualified to give it that they really are still sound.

I would also recommend not transferring any payment to ANY subscription
agent without taking out a banker's guarantee to cover the amount.

Had I been aware of divine's problems in September as opposed to December, I
would have considered myself very lucky.

In short, there is no smoke without a fire.

Pamela Ben-Eliezer
Shaare Zedek Medical Center
Medical Library
Jerusalem, Israel
ben-el@szmc.org.il

----- Original Message -----
From: "Kerry J. Gibson" <gibsonk@MVILLE.EDU>
To: <SERIALST@LIST.UVM.EDU>
Sent: Thursday, September 23, 2004 1:02 AM
Subject: [SERIALST] Financial Times about Swets

> I'm curious if anyone is currently being affected by this news piece.  Is
there merit in worrying?
>
> Kerry Gibson
>
>
> -----Original Message-----
> From: An informal list open to members of the serials community
[mailto:LIS-SERIALS@JISCMAIL.AC.UK]
> Sent: Tuesday, September 21, 2004 11:15 AM
> To: LIS-SERIALS@JISCMAIL.AC.UK
> Subject: FW: Financial Times about Swets
>
>
> Apologies if people have already seen this - thought it might be of
interest to list members.
>
>           Swets at brink of ruin after accounting fault banks demand
capital injection
>         Gerben Van Der Marel
>
>                 Amsterdam – Swets & Zeitlinger, Dutch distributors of
scientific information, are in trouble. The business needs refinancing after
it was found that it made losses in the past years.
>
>
>
>         As a consequence of the problems Swets no longer meets the credit
conditions of the bank. On Friday, shareholders will decide on a capital
injection of ˆ 45 million.
>
>                     This is confirmed by Jan-Willem Baud, chairman of the
board of supervisory directors. Baud is the director of NPM Capital, which
holds 26% of the shares of Swets. Other shareholders are the Swets family
(29%)[1] <outbind://51/#_ftn1> , Nesbic (23%), Paribas (15%), and Alpinvest
(7%). The business has approx. 1400 employees in 23 offices.
>
>                     NPM has promised new money. Baud: “We believe that
Swets can go on for another hundred years in spite of the problems.” Other
shareholders are still hesitant about whether or not they should jump to the
rescue, says Baud.
>
>                     Already in May it became public that Swets had found
‘errors’ in their books. And that hundreds of jobs will be scrapped.
>
>                     Just last year Swets was still being offered for sale
to international high-risk venture capitalists with a price tag of hundreds
of millions. One buyer, Candover, pulled out in the last minute.
>
>         Swets is an intermediary between scientific publishers and major
users such as universities. The company suffers from the increasing
distribution of information through the Internet. Attempts to become more
electronically active themselves have not panned out as predicted by the
management.
>
>                     The last figures published by Swets pertain to 2002,
when – according to the information – a turnover of ˆ 1.2 billion and a net
profit of ˆ 30.8 million were achieved. Swets now has to review the figures
over 2001, 2002, and 2003.
>
>                     According to Baud, transactions between parent
companies and subsidiaries were processed incorrectly for years. Swets
presently cannot give insight into the adjusted results. As a consequence of
debit transfers, which Baud does not want to specify, Swets ends up in the
red. “But non-recurring items do not get us into loss. Profits do have to
increase though.”
>
>                     Fraud, says Baud, was not discovered. Finance director
Eelco de Boer is said to have stumbled across errors of his predecessor
after taking up office last year. Whether these events will have
consequences for director Eric van Amerongen or other managers, Baud does
not want to disclose ahead of the shareholders’ meeting next Friday.
>
>
>   _____
>
>         [1] <outbind://51/#_ftnref1>  Wij verzoeken u dit getal te
controleren (niet goed leesbaar in de originele tekst).
>
>
>
>
>
>
>
>
> --
> Kerry Gibson
> Technical Services Librarian
> Manhattanville College Library
> Ph: (914) 323-7152
> Fx: (914) 694-8139
> gibsonk@mville.edu
> --
>
>
> **********************************************************************
> This message was checked by McAfee Antivirus !!! No viruses found
> **********************************************************************
> Shaare Zedek Medical Center - http://www.szmc.org.il
>
>
>

**********************************************************************
This message was checked by McAfee Antivirus !!! No viruses found
**********************************************************************
Shaare Zedek Medical Center - http://www.szmc.org.il